# Evaluation of Eflornithine on Facial and Forearm Skin

> **NCT00152048** · PHASE4 · COMPLETED · sponsor: **Allergan** · enrollment: 78 (—)

## Conditions studied

- Hirsutism

## Interventions

- **DRUG:** Eflornithine hydrochloride

## Key facts

- **NCT ID:** NCT00152048
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11-30
- **Primary completion:** —
- **Final completion:** 2005-10-31
- **Target enrollment:** 78 (—)
- **Last updated:** 2019-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00152048

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00152048, "Evaluation of Eflornithine on Facial and Forearm Skin". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT00152048. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*